Max Healthcare (India) Performance
MAXHEALTH | 979.75 2.90 0.30% |
Max Healthcare has a performance score of 6 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.0189, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Max Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Max Healthcare is expected to be smaller as well. Max Healthcare Institute right now secures a risk of 2.27%. Please verify Max Healthcare Institute kurtosis, and the relationship between the downside variance and day median price , to decide if Max Healthcare Institute will be following its current price movements.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Max Healthcare Institute are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating essential indicators, Max Healthcare may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
Forward Dividend Yield 0.0015 | Payout Ratio 0.1382 | Forward Dividend Rate 1.5 | Ex Dividend Date 2024-08-23 |
1 | Shareholders May Be More Conservative With Max Healthcare Institute Limiteds CEO Compensation For Now - Simply Wall St | 09/13/2024 |
2 | Max Healthcare shares gain 0.26 percent as Sensex rises - The Economic Times | 09/25/2024 |
3 | Share price of Max Healthcare falls as Sensex drops 1075.57 points - The Economic Times | 09/30/2024 |
4 | Max Healthcare share soars following acquisition of Jaypee Hospital - Yahoo Voices | 11/12/2024 |
5 | Max Healthcare shares 0.94 percent as Nifty - The Economic Times | 11/21/2024 |
Begin Period Cash Flow | 13.7 B |
Max |
Max Healthcare Relative Risk vs. Return Landscape
If you would invest 88,195 in Max Healthcare Institute on September 1, 2024 and sell it today you would earn a total of 9,780 from holding Max Healthcare Institute or generate 11.09% return on investment over 90 days. Max Healthcare Institute is generating 0.1894% of daily returns and assumes 2.2657% volatility on return distribution over the 90 days horizon. Simply put, 20% of stocks are less volatile than Max, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Max Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Max Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Max Healthcare Institute, and traders can use it to determine the average amount a Max Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0836
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | MAXHEALTH | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
2.27 actual daily | 20 80% of assets are more volatile |
Expected Return
0.19 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Max Healthcare is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Max Healthcare by adding it to a well-diversified portfolio.
Max Healthcare Fundamentals Growth
Max Stock prices reflect investors' perceptions of the future prospects and financial health of Max Healthcare, and Max Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Max Stock performance.
Return On Equity | 0.13 | ||||
Return On Asset | 0.0705 | ||||
Profit Margin | 0.18 % | ||||
Operating Margin | 0.21 % | ||||
Current Valuation | 956.38 B | ||||
Shares Outstanding | 972.13 M | ||||
Price To Book | 10.82 X | ||||
Price To Sales | 15.85 X | ||||
Revenue | 54.06 B | ||||
Gross Profit | 27.61 B | ||||
EBITDA | 16.7 B | ||||
Net Income | 10.58 B | ||||
Total Debt | 15.08 B | ||||
Book Value Per Share | 90.55 X | ||||
Cash Flow From Operations | 11.22 B | ||||
Earnings Per Share | 10.88 X | ||||
Total Asset | 120 B | ||||
Retained Earnings | 21.89 B | ||||
About Max Healthcare Performance
By examining Max Healthcare's fundamental ratios, stakeholders can obtain critical insights into Max Healthcare's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Max Healthcare is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Max Healthcare is entity of India. It is traded as Stock on NSE exchange.Things to note about Max Healthcare Institute performance evaluation
Checking the ongoing alerts about Max Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Max Healthcare Institute help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Max Healthcare is unlikely to experience financial distress in the next 2 years | |
About 24.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from news.google.com: Max Healthcare shares 0.94 percent as Nifty - The Economic Times |
- Analyzing Max Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Max Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Max Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Max Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Max Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Max Healthcare's stock. These opinions can provide insight into Max Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Max Stock
Max Healthcare financial ratios help investors to determine whether Max Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Max with respect to the benefits of owning Max Healthcare security.